What is the first-line management for acute rhinosinusitis?

First-Line Management of Acute Rhinosinusitis

For uncomplicated acute bacterial rhinosinusitis (ABRS), watchful waiting with symptomatic treatment is the preferred initial approach, reserving amoxicillin (with or without clavulanate) for patients with severe symptoms, those who fail to improve after 7 days, or those who worsen at any time. 1

Distinguishing Bacterial from Viral Rhinosinusitis

Before initiating any treatment, you must first determine whether the patient has viral or bacterial disease:

Diagnose ABRS when ANY of the following are present:

• Symptoms persisting ≥10 days without improvement 1, 2
• Severe symptoms (fever ≥39°C/102°F AND purulent nasal discharge or facial pain) for 3-4 consecutive days at illness onset 2
• "Double worsening" - initial improvement followed by worsening symptoms after 5-6 days 1, 2

If symptoms are present <10 days and not worsening, this is viral rhinosinusitis (VRS) - antibiotics are not indicated 3.

Initial Management Algorithm

For Viral Rhinosinusitis (symptoms <10 days, not worsening):

Symptomatic treatment only 1:

• Acetaminophen or ibuprofen for pain and fever
• Saline nasal irrigation (most effective supportive measure)
• Nasal decongestants (oral or topical for ≤3 days maximum to avoid rebound congestion)
• Nasal corticosteroid sprays (modest benefit after 15 days of use; NNT=14) 1

Do NOT use 1:

• Antibiotics
• Antihistamines (unless significant allergic component present)
• Oral corticosteroids routinely

For Acute Bacterial Rhinosinusitis:

Step 1: Assess Severity and Risk Factors

Offer watchful waiting (no antibiotics initially) if ALL of the following apply 1, 4:

• Mild-to-moderate symptoms (mild pain, temperature <38.3°C/101°F)
• No risk factors for antibiotic resistance
• Reliable follow-up assured within 7 days
• Patient understands to start antibiotics if worsening or no improvement by day 7

This approach is supported by Grade A evidence showing most patients improve spontaneously, with antibiotics providing only modest incremental benefit (NNT=10-15 for symptom relief) 1.

Initiate immediate antibiotic therapy if ANY of the following 2:

• Severe symptoms (moderate-to-severe pain OR fever ≥38.3°C/101°F)
• Risk factors for antibiotic resistance (age <2 or >65 years, daycare exposure, antibiotics within past month, recent hospitalization, comorbidities, immunocompromised)
• Patient preference after shared decision-making

Step 2: Antibiotic Selection When Indicated

First-line antibiotic: Amoxicillin 1, 2

• Standard dose for most adults
• Duration: 5-10 days (shorter courses equally effective with fewer side effects) 1
• Rationale: Effective, safe, inexpensive, narrow spectrum

Alternative first-line: Amoxicillin-clavulanate 1, 2

• Consider if risk factors for resistance present
• High-dose formulation (90 mg/kg amoxicillin component) for treatment failures 5

For penicillin allergy 5, 2, 6:

• Doxycycline
• Respiratory fluoroquinolone (levofloxacin or moxifloxacin)
• Trimethoprim-sulfamethoxazole (adults only)

Step 3: Adjunctive Symptomatic Treatment

Provide symptomatic relief regardless of antibiotic decision 1:

• Analgesics (acetaminophen or ibuprofen) based on pain severity
• Saline irrigation
• Nasal decongestants (≤3 days if topical)
• Nasal corticosteroid sprays (optional, modest benefit)

Reassessment and Treatment Failure

Reassess at 72 hours if patient reports worsening OR at 7 days if no improvement 1, 7, 2:

If initially managed with watchful waiting:

• Start amoxicillin or amoxicillin-clavulanate 1

If already on antibiotics:

• Switch to broader coverage (high-dose amoxicillin-clavulanate, respiratory fluoroquinolone, or second/third-generation cephalosporin) 5, 2
• Consider CT imaging to exclude complications or alternative diagnoses 1
• Refer to otolaryngology if no improvement after second antibiotic course

Critical Pitfalls to Avoid

1. Do not prescribe antibiotics for symptoms <10 days unless severe or worsening - this is almost always viral 1, 3

2. Do not routinely order imaging - plain radiographs have high false-positive/negative rates; CT is reserved for suspected complications or chronic disease 5, 3

3. Do not use antihistamines routinely - they worsen congestion by drying mucosa unless significant allergic component present 1, 4

4. Do not use broad-spectrum antibiotics as first-line - this increases resistance without improving outcomes 1

5. Ensure follow-up when using watchful waiting - patients must understand to contact you if worsening or no improvement by day 7 1, 4

Evidence Quality Note

The 2015 American Academy of Otolaryngology guidelines 1 represent the most authoritative and recent comprehensive guidance, with Grade A evidence supporting both watchful waiting and amoxicillin as first-line therapy. The 2025 update 4 reinforces these recommendations with continued emphasis on antibiotic stewardship. The IDSA 2012 guideline 2 provides complementary recommendations with similar conclusions but slightly different risk stratification approaches.